News
UIHC Kenny Lab Published in Cell-Press
Wednesday, March 26, 2025
Dr. Kristina Guyton, MD, shares advice for all ages as well as treatment options, KCRG reports.
Wednesday, March 26, 2025
Colorectal cancer is becoming one of the most common cancers among young people, but it's still a difficult topic to talk about. Colorectal surgeon Kristina Guyton, MD, shares advice for all ages as well as treatment options, KCRG reports.
Dr Weigel to receive SUS Lifetime Achievement Award
Thursday, February 27, 2025
The SUS is Pleased to Honor the 2024 SUS Lifetime Achievement Award Winner: Ronald J. Weigel, MD, PhD, MBA
Dr. Dionne Skeete to receive Distinguished Alumna Award for Service
Thursday, February 27, 2025
2025 University of Iowa Roy. J. and Lucille A. Carver College of Medicine Distinguished Alumna Award for Service
UI cancer researcher Po Hien Ear receives grant award to study rare neuroendocrine tumors
Tuesday, February 18, 2025
Po Hien Ear, PhD, assistant professor of surgery, has received funding from the Neuroendocrine Tumor Research Foundation (NETRF) to study cancer drug resistance in small bowel neuroendocrine tumors (SBNETs).
National Burn Awareness Week
Friday, January 31, 2025
Join the Movement: National Burn Awareness Week #NBAW Focuses on
Safer Living Spaces, February 2–8, 2025
Dr Samuel Jones appointmented as the Clara Smith Clinical Professor in Burn Treatment
Friday, January 10, 2025
This position was established to help promote and recognize Dr. Jones' outstanding academic achievements and contributions to the College.
Dr. Cullen's U. of Iowa trial uses Vitamin C to double the life expectancy of pancreatic cancer patients
Tuesday, December 10, 2024
By administering high doses of intravenous Vitamin C, researchers were able to extend the average prognosis from 8 months to 16 months.
High-dose IV vitamin C plus chemotherapy doubles survival in advanced pancreatic cancer
Thursday, November 14, 2024
High-dose, intravenous vitamin C doubles the survival rate of patients undergoing chemotherapy for late-stage metastatic pancreatic cancer, according to results from a phase 2 clinical trial led by Joe Cullen, MD.
Pagination